Yumanity Therapeutics Inc

NASDAQ:YMTX   11:17:40 AM EDT
1.08
-0.01 (-0.92%)
Earnings Announcements

Yumanity Therapeutics Reports Q1 2022 Results

Published: 05/12/2022 20:54 GMT
Yumanity Therapeutics Inc (YMTX) - Yumanity Therapeutics Reports First Quarter 2022 Financial Results and Recent Corporate Developments.
Q1 Loss per Share $1.24.
Revenue is expected to be $2.5 Million
Adjusted EPS is expected to be -$0.99

Next Quarter Revenue Guidance is expected to be $2.5 Million
Next Quarter EPS Guidance is expected to be -$1.08

More details on our Analysts Page.